REFERENCES
1.
Eichorn JH, Cooper JB, Cullen DJ, et al: Standards
for patient monitoring during anesthesia at Harvard Medical School. JAMA 256:1017–1020,
1986.
2.
Kotob F, Twersky RS: Anesthesia outside the operating
room: General overview and monitoring standards. Int Anesthesiol Clin 41(2):1–15,
2003.
3.
Guidelines of the American Society of Anesthesiologists:
Directory of Members, American Society of Anesthesiologists. Park Ridge, IL, American
Society of Anesthesiologists, 1997, p 404.
4.
Guidelines of the American Society of Anesthesiologists:
Directory of Members, American Society of Anesthesiologists. Park Ridge, IL, American
Society of Anesthesiologists, 1997, p 394.
5.
American Society of Anesthesiologists: Guidelines
for Determining Anesthesia Machine Obsolescence. ASA website: http://www.asahq.org/publicationsAndServices/machineobsolescencse.pdf,
2003.
6.
American Society of Anesthesiologists Task Force
on Sedation and Analgesia by Non-Anesthesiologists: Practice guidelines for sedation
and anesthesia by non-anesthesiologists. Anesthesiology 96:1004–1017, 2002.
7.
Shaughnessy TE: Sedation services for the anesthesiologist.
Anesthiol Clin North Am 17:355–363, 1999.
8.
Standards for Postanesthesia Care: Directory of
Members, American Society of Anesthesiologists. American Society of Anesthesiologists
Park Ridge, IL, 2001, pp 494–495.
9.
Reading CC: Ultrasound-guided ethanol ablation
of solid and cystic masses of the liver, kidney, thyroid, and parathyroid. Ultrasound
Q 12:67–88, 1994.
10.
Callstrom MR, Charboneau JW, Goetz MP, et al:
Painful metastases involving bone: Feasibility of percutaneous CT- and US-guided
radio-frequency ablation. Radiology 224:87–97, 2002.
11.
Nichols DA, Meyer FB, Piepgras DG, Smith PL: Endovascular
treatment of intracranial aneurysms. Mayo Clin Proc 69:272–285, 1994.
12.
Haslam PJ, Yap B, Mueller PR, Lee MJ: Anesthesia
practice and clinical trends in interventional radiology: A European survey. Cardiovasc
Intervent Radiol 23:256–261, 2000.
13.
National Council on Radiation Protection and Measurements:
Limitations of Exposure to Ionizing Radiation, report 116. Washington, DC, National
Council on Radiation Protection and Measurements, 1993.
14.
Goldberg M: Systemic reactions to intravascular
contrast media. A guide for the anesthesiologist. Anesthesiology 60:46–56,
1984.
15.
Dukes MNG: Radiological contrast media and radiopharmaceuticals.
In Dukes MNG (ed): Meyler's Side Effects of Drugs,
vol 13. New York, Elsevier, 1996, p 1382.
16.
Thomsen HS, Dorph S: High-osmolar and low-osmolar
contrast media: An update on frequency of adverse drug reactions. Acta Radiol 34:205–209,
1993.
17.
Siegle RL: Rates of idiosyncratic reactions:
Ionic versus nonionic contrast media. Invest Radiol 28(Suppl 5):S95–S98, 1993.
18.
Bettmann MA: Contrast agent use, regulation and
adverse events: Safety and efficacy of iodinated contrast agents. Invest Radiol
29(Suppl 1):S33, 1994.
19.
McClennan BL: Adverse reactions to iodinated contrast
media: Recognition and response. Invest Radiol 29(Suppl 1):S46–S50, 1994.
20.
Morcos SK, Thomsen HS: Adverse reactions to iodinated
contrast media. Eur Radiol 11:1267–1275, 2001.
21.
Marshall GD Jr, Lieberman PL: Comparison of three
pretreatment protocols to prevent anaphylactoid reactions to radio-contrast media.
Ann Allergy 67:70–74, 1991.
22.
Tepel M, Giet MVD, Schwarzfeld C, et al: Prevention
of radiographic contrast agent-induced reductions in renal function by acetylcysteine.
N Engl J Med 343:180–184, 2000.
23.
Kay J, Chow WH, Chan TM, et al: Acetylcysteine
for prevention of acute deterioration of renal function following elective coronary
angiography and intervention: A randomized controlled trial. JAMA 289:553–558,
2003.
24.
Diaz-Sandoval LJ, Kosowsky BD, Losordo DW: Acetylcysteine
to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol
89:356–358, 2002.
25.
Sirtori CR, Pasik C: Re-evaluation of a biguanide,
metformin: Mechanism of action and tolerability. Pharmacol Res 30:187–228,
1994.
26.
Joint Commission on Accreditation of Healthcare
Organizations: Accreditation Manual for Hospitals. Oak Brook, IL, JCAHO, 1991,
p 269.
27.
Keeter S, Benator RM, Weinberg SM, et al: Sedation
in pediatric CT: National survey of current practice. Radiology 175:745–752,
1990.
28.
Mueller PR, Wittenberg KH, Kaufman JA, et al:
Patterns of anesthesia and nursing care for interventional radiology procedures:
A national survey of physician practices and preferences. Radiology 202:339–343,
1997.
29.
Mason KP, Koka BV: Anesthesia for pediatric radiology.
Anesthesiol Clin North Am 17:479–502, 1999.
30.
American Society of Anesthesiologists Task Force
on Management of the Difficult Airway: An updated report by the American Society
of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology
98:1269–1277, 2003.
31.
Keeter S, Benator RM, Weinberg SM, Hartenberg MA:
Sedation in pediatric CT: National survey of current practice. Radiology 175:745–752,
1990.
32.
Goldberg SN, Gazelle GS, Compton SS, McCloud TC:
Radiofrequency tissue ablation in the rabbit lung: Efficacy and complications.
Acad Radiol 2:776–784, 1995.
33.
Dupuy DE, Zagoria RJ, Akerley W, et al: Percutaneous
radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 174:57–59,
2000.
34.
Herrera LJ, Fernando HC, Perry Y, et al: Radiofrequency
ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc
Surg 125:929–937, 2003.
35.
Vaughn C, Mychaskiw G, Sewell P: Massive hemorrhage
during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg 94:1149–1151,
2002.
36.
Menon DK, Peden CJ, Hall AS, et al: Magnetic resonance
for the anaesthetist. Part I: Physical principles, applications, safety aspects.
Anaesthesia 47:240–255, 1992.
37.
Gadian DG: Nuclear magnetic resonance theory.
In Nuclear Magnetic Resonance and Its Applications
to Living Systems. Oxford, Clarendon, 1982, p 143.
38.
Fundamentals of magnetic resonance imaging. Council
on Scientific Affairs. JAMA 258:3417–3423, 1987.
39.
Berger A: Magnetic resonance imaging. BMJ 324:35,
2002.
40.
Consensus Conference. Magnetic resonance imaging.
JAMA 14:2132–2138, 1988.
41.
Kanal E, Shellock FG, Talagala L: Safety considerations
in MR imaging. Radiology 76:593–606, 1990.
42.
Kanal E, Borgstede JP, Barkovich AJ, et al: American
College of Radiology White Paper on MRI Safety. AJR Am J Roentgenol 178:1335–1347,
2002.
43.
Achenbach S, Moshage W, Diem B, et al: Effects
of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 134:467–473,
1997.
44.
Goldschlager N, Epstein A, Friedman P, et al:
Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators:
A practical guide to patient treatment. Arch Intern Med 161:649–655, 2001.
45.
Wagle WA, Smith M: Tattoo-induced skin burn during
MR imaging. AJR Am J Roentgenol 174:1795, 2000.
46.
Tope WD, Shellock FG: Magnetic resonance imaging
and permanent cosmetics (tattoos): Survey of complications and adverse events.
J Magn Reson Imaging 15:180–184, 2002.
47.
Kremmer S, Schiefer U, Wilhelm H, Zrenner E: Mobilization
of intraocular foreign bodies by magnetic resonance tomography. Klin Monatsbl Augenheilkd
208:201–202, 1996.
48.
Klucznik RP, Carrier DA, Pyka R, Haid RW: Placement
of a ferromagnetic intracerebral aneurysm clip in a magnetic field with a fatal outcome.
Radiology 187:855–856, 1993.
49.
Shellock FG, Tkach JA, Ruggieri PM, et al: Aneurysm
clips: Evaluation of magnetic field interactions and translational attraction by
use of "long-bore" and "short-bore" 3.0-T MR imaging systems. AJNR Am J Neuroradiol
24:463–471, 2003.
50.
ECRI hazard report: Patient death illustrates
the importance of adhering to safety precautions in magnetic resonance environments.
Health Devices 30:311–314, 2001.
51.
Chaljub G, Kramer LA, Johnson RF, et al: Projectile
cylinder accidents resulting from the presence of ferromagnetic nitrous oxide or
oxygen tanks in the MR suite. AJR Am J Roentgenol 177:27–30, 2001.
52.
Peden CJ, Menon DK, Hall AS, et al: Magnetic resonance
for the anaesthetist. Part II: Anaesthesia and monitoring in MR units. Anaesthesia
47:508–517, 1992.
53.
Holshouser BA, Hinshaw DB Jr, Shellock FG: Sedation,
anesthesia, and physiologic monitoring during MR imaging: Evaluation of procedures
and equipment. J Magn Reson Imaging 3:553–558, 1993.
54.
Zorab JSM: A general anaesthesia service for magnetic
resonance imaging. Eur J Anaesthesiol 12:387–395, 1995.
55.
McBrien ME, Winer J, Smyth L: Anaesthesia for
magnetic resonance imaging: A survey of current practice in the UK and Ireland.
Anaesthesia 55:737–743, 2000.
56.
Gooden CK, Dilos B: Anesthesia for magnetic resonance
imaging. Int Anesthesiol Clin 41(2):29–37, 2003.
57.
Dempsey MF, Condon B: Thermal injuries associated
with MRI. Clin Radiol 56:457–465, 2001.
58.
Strother CM: Interventional neuroradiology. AJNR
Am J Neuroradiol 21:19–24, 2000.
59.
Hashimoto T, Dhanesh KG, Young WL: Interventional
neuroradiology—anesthetic considerations. Anesthesiol Clin North Am 20:347–359,
2002.
60.
Osborn IP: Anesthetic considerations for interventional
neuroradiology. Int Anesthesiol Clin 41(2):69–77, 2003.
61.
Young WL, Pile-Spellman J: Anesthetic considerations
for interventional neuroradiology. Anesthesiology 80:427–456, 1994.
62.
Sherry RG, Anderson RE, Kruger RE, Nelson JA:
Real-time digital subtraction angiography for therapeutic neuroradiologic procedures.
AJNR Am J Neuroradiol 4:1171–1174, 1983.
63.
Johnston S, Claiborne MD, Higashida RT, et al:
Recommendations for the endovascular treatment of intracranial aneurysms: A statement
for healthcare professionals from the Committee on Cerebrovascular Imaging of the
American Heart Association Council on Cardiovascular Radiology. Stroke 33:2536–2544,
2002.
64.
Vinuela F, Duckwiler G, Mawad M: Guglielmi detachable
coil embolization of acute intracranial aneurysm: Perioperative anatomical and clinical
outcome in 403 patients. J Neurosurg 86:475–482, 1997.
65.
Higashida RT, Halbach VV, Dowd CF, et al: Intracranial
aneurysms: Interventional neurovascular treatment with detachable balloons—results
in 215 cases. Radiology 178:663–670, 1991.
66.
Deveikis JP: Endovascular therapy of intracranial
arteriovenous malformations. Materials and techniques. Neuroimaging Clin N Am 8:401–424,
1998.
67.
Vinuela F, Dion JE, Duckwiler G, et al: Combined
endovascular embolization and surgery in the management of cerebral arteriovenous
malformations: Experience with 101 cases. J Neurosurg 75:856–864, 1991.
68.
Chang SD, Marcellus ML, Marks MP, et al: Multimodality
treatment of giant intracranial arteriovenous malformations. Neurosurgery 53:1–11,
2003.
69.
Pelz DM: Advances in interventional neuroradiology.
Stroke 34:357–358, 2003.
70.
Gress DR, Smith WS, Dowd CF, et al: Angioplasty
for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery 51:23–29,
2002.
71.
Lylyk P, Cohen JE, Cerratto R, et al: Angioplasty
and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR
Am J Neuroradiol 23:430–436, 2002.
72.
The National Institute of Neurologic Disorders
and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic
stroke. N Engl J Med 333:1581–1587, 1995.
73.
Wardlaw JM: Overview of Cochrane thrombolysis
meta-analysis. Neurology 57(5 Suppl 2):S69–S76, 2001.
74.
Vahedi K, Bousser MG: Thrombolysis in stroke.
Curr Opin Hematol 9:443–447, 2002.
75.
Wada J, Rasmussen T: Intracarotid injection of
sodium Amytal for the lateralization of cerebral speech dominance. J Neurosurg 17:266,
1960.
76.
Rauch RA, Viñuela F, Dion J, et al: Preembolization
functional evaluation in brain arteriovenous malformations: The ability of superselective
Amytal test to predict neurologic dysfunction before embolization. AJNR Am J Neuroradiol
13:309–314, 1992.
77.
Deveikis JP: Sequential injections of amobarbital
sodium and lidocaine for provocative neurologic testing in the external carotid circulation.
AJNR Am J Neuroradiol 17:1143–1147, 1996.
78.
Judkins MP: Selective coronary arteriography.
Part 1. A percutaneous transfemoral technic. Radiology 89:815–824, 1967.
79.
Scanlon PJ, Faxon DP, Audet AM, et al: ACC/AHA
guidelines for coronary angiography: Executive summary and recommendations. A report
of the American College of Cardiology/American Heart Association Task Force on practice
Guidelines (Committee on Coronary Angiography) developed in collaboration with the
Society for Cardiac Angiography and Interventions. Circulation 99:2345–2357,
1999.
80.
Kimmel SE, Berlin JA, Hennessy S, et al: Risk
of major complications from coronary angioplasty performed immediately after diagnostic
coronary angiography: Results from the Registry of the Society for Cardiac Angiography
and Interventions. J Am Coll Cardiol 30:193–200, 1997.
81.
Laskey W, Boyle J, Johnson LW: Multivariable model
for the prediction of significant complication during diagnostic cardiac catheterization.
The Registry Committee of the Society for Cardiac Angiography and Interventions.
Cathet Cardiovasc Diagn 30:185–190, 1993.
82.
Rihal CS, Holmes DR: Transradial cardiac catheterization:
Is femoral access obsolete? Am Heart J 138(Pt 1):392–393, 1999.
83.
Cooper CJ, El-Shiekh RA, Cohen DJ, et al: Effect
of transradial access on quality of life and cost of cardiac catheterization: A
randomized comparison. Am Heart J 138(Pt 1):430–436, 1999.
84.
Deutsch E: The emerging role of low-molecular
weight heparin and antiplatelet therapies in the cardiac catheterization laboratory.
Am Heart J 138(Pt 2):S577–S585, 1999.
85.
The EPIC Investigators: Use of a monoclonal antibody
directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary
angioplasty. N Engl J Med 330:956–961, 1994.
86.
Topol EJ, Califf RM, Weisman H, et al: Randomised
trial of coronary intervention with antibody against platelet IIb/IIIa integrin for
reduction of clinical restenosis: Results at six months. Lancet 343:881–890,
1994.
87.
The EPILOG Investigators: Platelet glycoprotein
IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.
N Engl J Med 336:1689–1696, 1997.
88.
The CAPTURE Investigators: Randomised placebo-controlled
trial of abciximab before and during coronary intervention in refractory unstable
angina: The CAPTURE study. Lancet 349:1429–1435, 1997.
89.
Ferguson JJ, Kereiakes DJ, Adgey AA, et al: Safe
use of platelet GP IIb/IIIa inhibitors. Eur Heart J 19(Suppl D):D40–D51, 1998.
90.
McIvor ME, Undemir C, Lawson J, Reddinger J: Clinical
effects and utility of intracoronary diltiazem. Cathet Cardiovasc Diagn 35:287–291,
1995.
91.
Barnes RD, Abel MD, Rihal CS: Anesthesia and interventional
cardiology. In Thys DM, Hillel Z, Schwartz AJ (eds):
Cardiothoracic Anesthesiology. New York, McGraw-Hill, 2001.
92.
Kiemeneij F, Laarman GJ, Odekerken D, et al: A
randomized comparison of percutaneous transluminal angioplasty by the radial, brachial,
and femoral approaches: The access study. J Am Coll Cardiol 29:1269–1275,
1997.
93.
Vlietstra RE, Holmes DR Jr, Smith HC, et al: Percutaneous
transluminal coronary angioplasty: Initial Mayo Clinic experience. Mayo Clin Proc
56:287–293, 1981.
94.
Holmes DR Jr, Garratt KN, Isner JM, et al: Effect
of subintimal resection on initial outcome and restenosis for native coronary lesions
and saphenous vein graft disease treated by directional coronary atherectomy: A
report from the CAVEAT I and II investigators. Coronary Angioplasty Versus Excisional
Atherectomy Trial. J Am Coll Cardiol 28:645–651, 1996.
95.
Neuhaus KL, Zeymer U: Prevention and management
of thrombotic complications during coronary interventions. Combination therapy with
antithrombins, antiplatelets, and/or thrombolytics: Risks and benefits. Eur Heart
J 16(suppl L):63–67, 1995.
96.
Adgey AA: Bleeding complications with new antithrombotics
used in ischaemic heart disease. Haemostasis 26:237–246, 1996.
97.
Heikkinen L, Virtanen K, Heikkila J, et al: Surgical
treatment of acute myocardial ischaemia related to coronary angioplasty with special
reference to use of perfusion balloon catheter and long-term outcome. J Cardiovasc
Surg (Torino) 38:101–106, 1997.
98.
Berger PB, Stensrud PE, Daly RC, et al: Time to
reperfusion and other procedural characteristics of emergency coronary artery bypass
surgery after unsuccessful coronary angioplasty. Am J Cardiol 76:565–569,
1995.
99.
Schwartz RS, Topol EJ, Serruys PW, et al: Artery
size, neointima, and remodeling: Time for some standards. J Am Coll Cardiol 32:2087–2094,
1998.
100.
Umans VA, Melkert R, Foley DP, Serruys PW: Clinical
and angiographic comparison of matched patients with successful directional coronary
atherectomy or stent implantation for primary coronary artery lesions. J Am Coll
Cardiol 28:637–644, 1996.
101.
Garza L, Aude YW, Saucedo JF: Can we prevent
in-stent restenosis? Curr Opin Cardiol 17:518–525, 2002.
102.
Rubin P, Soni A, Williams JP: The molecular and
cellular biologic basis for the radiation treatment of benign proliferative diseases.
Semin Radiat Oncol 9:203–214, 1999.
103.
Leon MB, Teirstein PS, Moses JW, et al: Localized
intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after
stenting. N Engl J Med 334:250–256, 2001.
104.
Kleinman NS, Califf RM: Late-breaking clinical
trials. J Am Coll Cardiol 36:310–325, 2000.
105.
Waksman R, Raizner AE, Yeung AC, et al: Localized
intracoronary beta radiation therapy to inhibit recurrence of in-stent restenosis.
Lancet 359:551–557, 2002.
106.
Lange RA, Hillis LD: Immediate angioplasty for
acute myocardial infarction. N Engl J Med 328:726–728, 1993.
107.
Gibbons RJ, Holmes DR Jr, Reeder GS, et al: Immediate
angioplasty compared with the administration of a thrombolytic agent followed by
conservative treatment for myocardial infarction. The Mayo Coronary Case Unit and
Catheterization Laboratory Groups. N Engl J Med 328:685–691, 1993.
108.
de-Bruijn NP, Hlatky MA, Jacobs JR et al: General
anesthesia during percutaneous transluminal coronary angioplasty for acute myocardial
infarction: Results of a randomized controlled clinical trial. Anesth Analg 68:201–207,
1989.
109.
Shawl FA, Baxley WA: Role of percutaneous cardiopulmonary
bypass and other support devices in interventional cardiology. Cardiol Clin 12:543–557,
1994.
110.
Suarez de Lezo J, Pan M, Medina A, et al: Percutaneous
cardiopulmonary support in critical patients needing coronary interventions with
stents. Cathet Cardiovasc Interv 57:467–475, 2002.
111.
Manners JM, Codman VA: General anesthesia for
cardiac catheterization in children: The effect of spontaneous or controlled ventilation
on the evaluation of congenital abnormalities. Anaesthesia 24:541–553, 1969.
112.
Korten K: Anesthesia for diagnostic procedures.
Am Fam Physician 15:103–107, 1977.
113.
Manners JM: Anaesthesia for diagnostic procedures
in cardiac disease. Br J Anaesth 43:276–287, 1971.
114.
Berman W Jr, Fripp RR, Rubler M, Alderete L:
Hemodynamic effects of ketamine in children undergoing cardiac catheterization.
Pediatr Cardiol 11:72–76, 1990.
115.
Reich DL, Silvay G: Ketamine: An update on the
first twenty-five years of clinical experience. Can J Anaesth 36:186–197,
1989.
116.
Coppel DL, Dundee JW: Ketamine anaesthesia for
cardiac catheterization. Anaesthesia 27:25–31, 1972.
117.
Faithfull NS, Haider R: Ketamine for cardiac
catheterization: An evaluation of its use in children. Anaesthesia 26:318–323,
1971.
118.
Lebovic S, Reich DL, Steinberg LG, et al: Comparison
of propofol versus ketamine in pediatric patients undergoing cardiac catheterization.
Anesth Analg 74:490–494, 1992.
119.
Rautiainen P: Alfentanil infusion for sedation
in infants and small children during cardiac catheterization. Can J Anaesth 38:980–984,
1991.
120.
Meretoja OA, Rautiainen P: Alfentanil and fentanyl
sedation in infants and small children during cardiac catheterization. Can J Anaesth
37:624–628, 1990.
121.
Kan JS, White RI Jr, Mitchell SE, et al: Percutaneous
balloon valvuloplasty: A new method for treating congenital pulmonary-valve stenosis.
N Engl J Med 307:540, 1982.
122.
Allen HD, Beekman RH III, Gason A Jr, et al:
Pediatric therapeutic cardiac catheterization: A statement for healthcare professionals
from the Council on Cardiovascular Disease in the Young, American Heart Association.
Circulation 97:609–625, 1998.
123.
Cribier A, Savin T, Saoudi N, et al: Percutaneous
transluminal valvuloplasty of acquired aortic stenosis in elderly patients: An alternative
to valve replacement? Lancet 1:63–67, 1986.
124.
Magee AG, Qureshi SA: Closure of atrial septal
defects by transcatheter devices. Pediatr Cardiol 18:326–327, 1997.
125.
Hekmat K, Mehlhorn U, Rainer de Vivie E: Surgical
repair of a large residual atrial septal defect after transcatheter closure. Ann
Thorac Surg 63:1456–1458, 1997.
126.
Sigwart U: Non surgical myocardial reduction
for hypertrophic obstructive cardiomyopathy. Lancet 346:211–213, 1995.
127.
Lakkis N: New treatment methods for patients
with hypertrophic obstructive cardiomyopathy. Curr Opin Cardiol 15:172–177,
2000.
128.
Singh M, Edwards WD, Holmes DR Jr, et al: Anatomy
of the first septal perforating artery: A study with implications for ablation therapy
for hypertrophic cardiomyopathy. Mayo Clin Proc 76:799–802, 2001.
129.
Vanderheyden M, Willaert W, Claessens P: Nonalcoholic
percutaneous transluminal septal ablation for hypertrophic cardiomyopathy with obstruction.
Am J Cardiol 89:361–362, 2002.
130.
Hammill SC, Sugrue DD, Gersh BJ, et al: Clinical
intracardiac electrophysiologic testing: Technique, diagnostic indications, and
therapeutic uses. Mayo Clin Proc 61:478–503, 1986.
131.
Davis J, Scheinman MM, Ruder MA, et al: Ablation
of cardiac tissues by an electrode catheter technique for treatment of ectopic supraventricular
tachycardia in adults. Circulation 74:1044–1053, 1986.
132.
Lavoie J, Walsh EP, Burrows FA, et al: Effects
of propofol or isoflurane anesthesia on cardiac conduction in children undergoing
radiofrequency catheter ablation for tachydysrhythmias. Anesthesiology 82:884–887,
1995.
133.
Sharpe MD, Dobkowski WB, Murkin JM, et al: Propofol
has no direct effect on sinoatrial node function or on normal atrioventricular and
accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam
anesthesia. Anesthesiology 82:888–895, 1995.
134.
Vazir-Marino F, Young ML, Kohli V, et al: Controlled
ventilation enhances catheter stability during radiofrequency ablation. Pacing Clin
Electrophysiol 22(Pt 1):86–90, 1999.
135.
Kerber RE: Transthoracic cardioversion of atrial
fibrillation and flutter: Standard techniques and new advances. Am J Cardiol 78(8A):22–26,
1996.
136.
Sternlo JE, Hagerdal M: Anaesthesia for cardioversion—clinical
experiences with propofol and thiopentone. Acta Anaesthesiol Scand 35:606–608,
1991.
137.
Canessa R, Lema G, Urzua J, et al: Anesthesia
for elective cardioversion: A comparison of four anesthetic agents. J Cardiothorac
Vasc Anesth 5:566–568, 1991.
138.
Ford SR, Maze M, Gaba DM: A comparison of etomidate
and thiopental anesthesia for cardioversion. J Cardiothorac Vasc Anesth 5:563–565,
1991.
139.
Fennelly ME, Powell H, Galletly DC, Whitwam JG:
Midazolam sedation reversed with flumazenil for cardioversion. Br J Anaesth 68:303–305,
1992.
140.
Rasmussen KG, Sampson SM, Rummans TA: Electroconvulsive
therapy and newer modalities for the treatment of medication-refractory mental illness.
Mayo Clin Proc 77:552–556, 2002.
141.
Potter WZ, Rudorfer MV: Electroconvulsive therapy—a
modern medical procedure. N Engl J Med 328:882–883, 1993.
142.
Selvin BL: Electroconvulsive therapy—1987.
Anesthesiology 67:367–385, 1987.
143.
Walker R, Swartz CM: Electroconvulsive therapy
during high-risk pregnancy. Gen Hosp Psychiatry 16:348–353, 1994.
144.
Sanacora G, Mason GF, Rothman DL, et al: Increased
cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry
160:577–579, 2003.
145.
Saito S, Miyoshi S, Yoshikawa D, et al: Regional
cerebral oxygen saturation during electroconvulsive therapy: Monitoring by near-infrared
spectrophotometry. Anesth Analg 83:726–730, 1996.
146.
McCall WV: Asystole in electroconvulsive therapy:
Report of four cases. J Clin Psychiatry 57:199–203, 1996.
147.
Ring BS, Parnass SM, Shulman RB, et al: Cardiogenic
shock after electroconvulsive therapy. Anesthesiology 84:1511–1513, 1996.
148.
Dec GW Jr, Stern TA, Welch C: The effects of
electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values.
A prospective study of depressed hospitalized inpatients. JAMA 253:2525–2529,
1985.
149.
Cockey GH, Conti CR: Electroconvulsive therapy-induced
transient T-wave inversions on ECG. Clin Cardiol 18:418–420, 1995.
150.
Rice EH, Sombrotto LB, Markowitz JC, Leon AC:
Cardiovascular morbidity in high-risk patients during ECT. Am J Psychiatry 151:1637–1641,
1994.
